1. Home
  2. Companies
  3. ADR
  4. Material Events

Adherium (ASX:ADR) — Material Events

ASX:ADR · 17 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Significant 13 articles Notable 4 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
13
Adherium Raises A$7.52M to Accelerate US Rollout of SmartInhaler PlatformMedium
Adherium launches A$7.52M equity raise to accelerate US RPM commercialisation targeting asthma and COPD markets
16 Feb 2026 ·Equity Raising Investor Presentation ·85
Adherium Accelerates U.S. RPM Rollout with Allergy Partners, Activates 70% ClinicsMedium
Adherium Hits Key Commercial Milestone with Allergy Partners RPM Expansion
26 Nov 2025 ·ASX Announcement ·85
Adherium’s iCARE Study Reveals Breakthrough in COPD and Asthma Medication AdherenceMedium
Adherium's iCARE Study Shows Breakthrough Adherence and Cost Reductions in COPD and Asthma Care
15 Sept 2025 ·ASX Announcement ·85
Adherium Doubles RPM Revenue as Device Shipments Surge in 2025Medium
Adherium reports over 100% Q2 RPM revenue growth and on track for 4,000 device shipments in 2025
16 Dec 2025 ·Quarterly Sales Update ·85
Adherium Surges Past 2025 Targets with 234% Quarterly Growth in Smartinhaler ShipmentsMedium
Adherium exceeds 2025 shipment targets with strong RPM growth and improved US reimbursement
30 Jan 2026 ·Appendix 4C Quarterly Cash Flow Report ·85
Adherium Accelerates Growth with 55% Shipment Surge and $2.6M Funding BoostMedium
Adherium reports 55% shipment growth, strong iCARE study results, and $2.6M funding secured post-quarter
31 Oct 2025 ·Quarterly Cash Flow Report ·85
Adherium Accelerates RPM Growth with 51% Revenue Surge and New Billing CodesMedium
Adherium reports 51% RPM revenue growth and strong device activation, targets 10,000 RPM patients in 2026
10 Mar 2026 ·Sales Update ·80
Adherium Surpasses 2025 Shipment Targets, Accelerating RPM GrowthMedium
Adherium surpasses 2025 shipment targets with 4,600+ devices shipped, driving RPM growth
24 Dec 2025 ·Operational Update ·80
Adherium Taps Dawn Bitz to Accelerate Global Growth of Hailie® PlatformMedium
Adherium appoints Dawn Bitz as CEO to drive global growth of Hailie® respiratory platform
22 July 2025 ·Executive Appointment ·80
Adherium Surges 30% in US Patient Growth, Raises $4.5M to Fuel ExpansionMedium
Adherium reports 30% US patient growth, raises $4.5M in capital raise, appoints new CEO
31 July 2025 ·Appendix 4C Quarterly Cash Flow Report ·80
Adherium Secures $4.49M to Accelerate Digital Respiratory Health GrowthMedium
Adherium completes $4.49M entitlement offer to scale respiratory health platform
17 July 2025 ·Capital Raising ·75
Adherium Posts $12.68M Loss Amid US Expansion and Capital RaiseMedium
Adherium posts $12.68M loss, boosts US market spend, raises $4.49M capital
29 Aug 2025 ·Appendix 4E Preliminary Financial Statements ·75
Adherium Secures $6.7M to Accelerate Remote Patient Monitoring GrowthMedium
Adherium raises AUD 6.7M via Placement and Institutional Entitlement Offer to fuel growth in remote patient monitoring and US insurer contracts
18 Feb 2026 ·Capital Raising ·75
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.